P100010/S154: STOP Persistent AF
FDA’s recorded scope: approval of the early termination for the post-approval study (PAS) referenced above.
Explore this company’s associated devices, FDA decisions and regulatory history.

MedtechLedger currently links 5 FDA records to the applicant name Medtronic Cryocath, LP. It includes 1 original PMA approval. 4 entries are PMA supplements. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Dec 17, 2010 to Sep 25, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code OAE appears in 4 of the 5 linked filings. The collection spans 2 FDA product codes and 2 original PMA application families. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
The largest PMA family in this collection is P100010, with 4 linked entries. Follow the parent application and its dated supplements to distinguish the original device scope from later changes. 1 linked filing has a current plain-language explanation checked against the recorded FDA decision.
Applicant mailing address recorded by FDA: 8200 Coral Sea St., Ms Mv S46, Mounds View, MN, 55112. Recorded on P100010/S154, decision dated Sep 25, 2026.
Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Fibrillation; Cardiac Ablation Percutaneous Catheter.
FDA’s recorded scope: approval of the early termination for the post-approval study (PAS) referenced above.
FDA’s recorded scope: approval of the early termination for the post-approval study (PAS) referenced above. The PAS protocol has been submitted to comply with the conditions of approval outlined in our approval order for P100010/S110.
FDA’s recorded scope: approval for Freezor Coaxial Connector Adhesive Modifications
FDA’s recorded scope: approval for Freezor Coaxial Connector Adhesive Modifications
The FDA database entry for P100010 records an approval decision dated December 17, 2010, for the Arctic Front Cryocatheter System from Medtronic Cryocath, LP. The device is categorized as a percutaneous cardiac ablation catheter for treatment of atrial fibrillation under product code OAE.
The approval statement lists the indication as treatment of drug refractory recurrent symptomatic paroxysmal atrial fibrillation. The entry does not include supplement type, supplement reason, or other fields describing a changed item or original scope, so no further detail about the approval's relationship to any prior PMA is available from these fields.
APPROVAL OF THE ARCTIC FRONT CRYOCATHETER SYSTEM. THE DEVICE IS INDICATED FOR THE TREATMENT OF DRUG REFRACTORY RECURRENT SYMPTOMATIC PAROXYSMAL ATRIAL FIBRILLATION.
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
Source updated Nov 9, 2026. Retrieved Nov 21, 2026.